Incident: A letter of intent was signed with the actual controller Zhang Hui, the parent company, and the parent company's holding subsidiary to acquire no less than 51% of the shares in Beijing Harmonious Rehabilitation Hospital held by the first three. Comment: 1) Accelerate the transformation of medical care and form a synergy with Internet healthcare. Recently, the two Internet medical companies that the company is currently implementing acquisitions mainly lay out online Internet medical treatment, and the current acquisition of Harmonious Rehabilitation Hospital realizes the interconnection and complementarity of medical resources online and offline. 2) Harmony Rehabilitation Hospital specializes in treating cerebral palsy. According to WHO statistics, the incidence of neonatal “cerebral palsy” is between 2-5％. According to official data from the China Disabled Welfare Foundation, there are currently about 1.75 million “cerebral palsy” patients in China, of which there are about 310,000 children aged 0 to 6, and the number is increasing by 46,000 every year. Currently, Harmonious Rehabilitation Hospital has 120 beds and an estimated annual profit of about 15 million yuan; it mainly features minimally invasive acupuncture and microsurgical rehabilitation treatment for cerebral palsy. The projects cover various medical fields such as cerebral palsy, hemiplegia, paraplegia, orthopedics, and post-operative rehabilitation. Academic leader Professor Ren Yuelin is the director of the hospital. He is the founder of minimally invasive acupuncture treatment technology for cerebral palsy in China, the chairman of the Chinese Society of Traditional Chinese Medicine's Minimally Invasive Acupuncture Professional Committee, and the vice president of the Acupuncture and Knife Professional Committee of the Federation of Traditional Chinese Medicine Societies. He has been engaged in research and diagnosis of cerebral palsy for more than 30 years. “Acupuncture and Minimally Invasive Cerebral Palsy Treatment Technology” won the second prize of the Chinese Society of Traditional Chinese Medicine Science and Technology Award in 2011. The hospital is the leader unit of the Chinese Society of Traditional Chinese Medicine Minimally Invasive Cerebral Palsy Treatment and Rehabilitation Expert Group. Valuation rating: The company's transformation from real estate to pharmaceuticals is typical, breaking through bottlenecks in industry development, opening up room for growth, and enjoying high premiums. EPS is expected to be 0.01 yuan, 0.02 yuan, and 0.03 yuan respectively in 15-17, giving an increase in holdings ratings. Risk warning: The layout of the medical sector falls short of expectations.